NORTHBROOK, IL -- (Marketwired) -- 06/03/13 -- Nanosphere, Inc., (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's President and Chief Executive Officer Michael McGarrity at the Jefferies 2013 Global Healthcare Conference, being held at the Grand Hyatt Hotel in New York City. The Company presentation is on Wednesday, June 5 at 2:00pm Eastern Time.
A live webcast of Nanosphere's presentation will be available at www.nanosphere.us.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic, and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple, and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere is based in Northbrook, IL.
For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting@nanosphere.us or visit www.nanosphere.us.
Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Chief Financial Officer
LifeSci Advisors, LLC
Most Popular Stories
- Pickup Discounts Boost September Auto Sales
- Kurdish Militia Still Lack Weapons, Training
- Review: Pay by Phone or Just Keep Using Plastic?
- Lexus Luxury Compact Sedan Wins Buyers
- N.Y. Ups Awards of State Contracts to Minorities
- Ebola Victim Was Sent Home by Dallas Hospital
- Dallas Parents Fear Students Exposed to Ebola
- Group Offers Online Help for College Students
- Baker Hughes to Disclose Fracking Chemicals
- Why the Bond Market Isn't as Safe as You Think